# Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

> **NCT05834478** · PHASE3 · RECRUITING · sponsor: **Emory University** · enrollment: 103 (estimated)

## Conditions studied

- Withdrawal Symptoms
- Opioid Use Disorder
- Opioid Use

## Interventions

- **DEVICE:** Transcutaneous Cervical Vagal Nerve Stimulation
- **DEVICE:** Sham Stimulation
- **DRUG:** [F-18]Fallypride

## Key facts

- **NCT ID:** NCT05834478
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-20
- **Primary completion:** 2027-02
- **Final completion:** 2027-04
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05834478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05834478, "Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05834478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*